METASTATIC UROTHELIAL CARCINOMA
Clinical trials for METASTATIC UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shield patients from chemo side effects in bladder cancer battle
Disease control Not yet recruitingThis early-stage study is testing whether adding an investigational drug called GB-4362 to a standard two-drug regimen can make treatment safer for adults with advanced bladder cancer. GB-4362 is designed to neutralize a specific chemotherapy component that causes side effects li…
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Massive 3,000-Patient study to track real bladder cancer treatment outcomes
Knowledge-focused Not yet recruitingThis study aims to understand how well current treatments work for advanced bladder cancer in everyday medical practice. Researchers will review existing health records of 3,000 U.S. patients who started treatment after April 2023. The study will track how long treatments keep th…
Matched conditions: METASTATIC UROTHELIAL CARCINOMA
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC